Navigation Links
A*STAR signs agreement with Nestlé to strengthen food & nutrition R&D in Singapore
Date:1/22/2014

1. Singapore's Agency for Science, Technology and Research (A*STAR) has entered into a research agreement with Nestl today to help boost the company's expansion in R&D in the country. This agreement signed by the two organisations will set the stage for cutting-edge research in areas including packaged food and beverages, food ingredients, nutrition, food manufacturing processes, food science and technology, as well as biotransformation .

2. The framework research agreement will bring together both partners' capabilities and expertise in a range of advanced technologies and research fields that will help Nestl to optimise its production processes and to provide nutritional foods for Nestl's consumers. A*STAR has been developing research capabilities in food and nutrition as one of its five strategic research priorities in the biomedical sciences. This partnership will thus also boost A*STAR's capabilities as the research collaborator of choice in Asia for the global food and nutrition industry.

3. As Asian consumers become more educated and affluent, many food and nutrition companies like Nestl are responding by developing food, health and wellness products customised for Asian markets. In four years, Singapore's total manufacturing output for the food manufacturing sector increased from S$5.7 billion in 2007 to S$8.4 billion in 2011, while the value-added manufacturing output almost doubled from S$1.2 billion to S$2.1 billion. The number of workers employed in food manufacturing also increased 20 per cent over the same time period.

4. The agreement, which involves the participation of all 18 A*STAR research entities, will provide opportunities for researchers across A*STAR to embark on collaborations with Nestl's affiliates globally. A*STAR recently launched a joint centre with National University of Singapore (NUS) - Singapore Centre for Nutritional Sciences, Metabolic Diseases, and Human Development (SiNMeD) to advance research on nutrition, early development and metabolic disease. This agreement will also allow Nestl access to A*STAR's research facilities and technology.

5. Mr Lim Chuan Poh, Chairman of A*STAR said, "A*STAR is looking forward to this excellent opportunity to broaden and deepen the work that we do with the world's leading food and nutrition company to expand their R&D capabilities in Singapore. This agreement marks a significant milestone in propelling forward A*STAR's research thrust into food and nutrition."

6. Stefan Catsicas, Nestl Chief Technology Officer, Head of Innovation, Technology, Research & Development said, "We are delighted to sign this research agreement with A*STAR. It provides the framework for future collaboration that will help to strengthen our food science and technology capabilities in Singapore and beyond."

7. A*STAR has also previously embarked on research projects with Nestl through the EpiGen consortium , to understand optimal nutrition for mothers during pregnancy and for infants to promote metabolic health throughout life.


'/>"/>

Contact: Vithya Selvam
vithya_selvam@a-star.edu.sg
656-826-6291
Agency for Science, Technology and Research (A*STAR), Singapore
Source:Eurekalert  

Related biology news :

1. A*STAR scientists discover novel hormone essential for heart development
2. A*STAR scientists groundbreaking discovery of nucleus structure crucial to understanding diseases
3. A*STAR scientists solve century-old mystery by finding stable haploid strains of Candida albicans
4. A*STAR scientists discover potential drug for deadly brain cancer
5. Breakthroughs in Chikungunya research from A*STAR spell new hope for better treatment and protection
6. Research reveals new understanding, warning signs, and potential treatments for multiple sclerosis
7. Switzerland signs the ELIXIR consortium agreement and contributes €35 million
8. BioClaim, Inc. Signs Biometric Software Contract with Amerigroup Florida
9. Leopoldina signs cooperation agreement with the Academy of Science of South Africa
10. Fluke Biomedical launches portable, feature-rich ProSim 3 and 2 Vital Signs Simulators
11. Light and nanoprobes detect early signs of infection
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
A*STAR signs agreement with Nestlé to strengthen food & nutrition R&D in Singapore
(Date:4/5/2017)... -- KEY FINDINGS The global market for ... of 25.76% during the forecast period of 2017-2025. The ... the growth of the stem cell market. ... INSIGHTS The global stem cell market is segmented on ... stem cell market of the product is segmented into ...
(Date:4/3/2017)... WASHINGTON , April 3, 2017 /PRNewswire-USNewswire/ ... single-cell precision engineering platform, detected a statistically ... cell product prior to treatment and objective ... highlight the potential to predict whether cancer ... prior to treatment, as well as to ...
(Date:3/30/2017)... 2017 The research team of The Hong ... fingerprint identification by adopting ground breaking 3D fingerprint minutiae recovery and ... speed and accuracy for use in identification, crime investigation, immigration control, ... ... A research team led ...
Breaking Biology News(10 mins):
(Date:6/20/2017)... , June 20, 2017  Kibow Biotech Inc., a ... announce the issuance of a new patent covering a ... by the U.S. Patent and Trademark Office on May ... of the Buzz of Bio award in 2014 in ... to developing non-drug approaches to chronic disease. Renadylâ„¢, the ...
(Date:6/19/2017)... ... 19, 2017 , ... As Vice President, Product Services, Mr. ... implementation, support, and client process and SOP development. , Mr. Guinter brings a ... roles for service providers and top-tier pharmaceuticals, and as an independent consultant supported ...
(Date:6/16/2017)... Lexington, Massachusetts (PRWEB) , ... June 16, 2017 ... ... in medical device compliance and commercialization, has just announced two more sessions of ... of the series will focus on the world of online templates for design ...
(Date:6/15/2017)... ... June 15, 2017 , ... Cybrexa ... Series B round of financing in the amount of $6 million. An investment ... participated in the round. , The Series B funding will enable Cybrexa to ...
Breaking Biology Technology: